Building on its Canadian launch and the historic introduction of generic semaglutide, Hims & Hers brings the full power of the world's largest consumer health platform — and Juniper's proven track record — to more Canadians than ever

Company Website: https://www.hims.com
TORONTO -- (Business Wire)

Hims & Hers Health, Inc. today announced the completion of its acquisition of Eucalyptus, the parent company of Juniper, marking the latest in a series of significant company investments in Canada. Since launching in 2025, Hims & Hers has already changed the game in Canada, becoming the first platform to bring generic semaglutide to eligible Canadians. By combining Juniper's proven platform with the technology, data, and clinical infrastructure that has advanced Hims & Hers’ position as the world's largest consumer health platform, more Canadians can benefit from preventive, whole-body care than ever before.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260602648634/en/

Building on its Canadian launch and the historic introduction of generic semaglutide, Hims & Hers brings the full power of the world's largest consumer health platform — and Juniper's proven track record — to more Canadians than ever

In a country where nearly two thirds of adults are overweight or living with obesity, the need for accessible, personalised weight management care has never been greater. Juniper has built one of the most trusted weight management programs in the markets it serves, pairing personalised treatment with consistent, high-touch clinical support. This expanded platform will allow Hims & Hers to delve into additional areas of care where Canadians have historically lacked access, including sexual health, and hair loss, building a platform that supports health across every adult stage of life.

Canada's healthcare system delivers strong foundational care, but meaningful gaps remain around prescription affordability, chronic disease management, and preventive health. Hims & Hers is committed to closing those gaps, helping Canadians access personalised, preventive care before conditions escalate, reducing long-term health burdens and helping people live longer, healthier lives.

"From being first to market with generic semaglutide to completing this acquisition, every step for Hims & Hers in Canada has been guided by that same purpose: expanding access to the care Canadians need, when they need it," said Andrew Dudum, co-founder and CEO of Hims & Hers. "We are committed to helping Canadians live fuller, more vibrant lives by building something different — preventive, personalised care that’s built around how people actually live."

A local clinical approach remains central to how Hims & Hers operates in Canada. Patients will continue to be connected with Canadian providers who understand the healthcare landscape they are navigating, bringing the local expertise and clinical rigour this kind of care demands. For patients already receiving care through Juniper, treatment continues uninterrupted. Joining Hims & Hers gives the team the resources and reach to keep building on a model patients have come to trust, with more behind it than ever before.

"Hims & Hers is here to build something lasting for Canadian health, and we've moved fast to prove it," said Austin Kouri, General Manager, Hims & Hers Canada. "We are the digital health platform Canadians can trust, providing access to specialized, affordable care grounded in local expertise. We look forward to supporting every Canadian across their journey toward a healthier, more fulfilling life."

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalised care designed for results. For more information, please visit www.hims.ca and www.forhers.ca.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and “forward-looking information” within the meaning of applicable Canadian securities legislation (collectively, “forward-looking statements”). The forward-looking statements contained in this press release are expressly qualified by this cautionary statement and readers are cautioned not to put undue reliance on them. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assume,” “may,” “can,” “will,” “likely,” “potential,” “occur,” “projects,” “predicts,” “continue,” “goal,” “objective,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “project,” “confidence,” “foundation,” “groundwork,” or “could,” “should,” “would,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding Hims & Hers’ expansion into Canada, the anticipated benefits of the acquisition of Eucalyptus, the expected timing and potential launch of new products or offerings, and assumptions relating to the foregoing. These forward-looking statements are based on management’s current expectations, but actual results may differ materially due to various factors.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this press release are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, uncertainties relating to the integration of Eucalyptus; our ability to successfully expand into new markets or specialties; our ability to launch new products or offerings on expected timelines or at all; expectations regarding market acceptance, user experience and customer retention; changes in healthcare, consumer protection or privacy laws; increased scrutiny from regulators; the impact of general economic, business, or financial conditions; and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission as well as additional risks and uncertainties inherent to Hims & Hers’ business, not currently known by Hims & Hers, that are out of Hims & Hers’s control or that Hims & Hers currently deems to be immaterial, which could also have a material adverse effect on Hims & Hers or on its ability to successfully integrate the acquisition of Eucalyptus.

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this press release are made only as of the date of this press release. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. If Hims & Hers updates any one or more forward-looking statements, no inference should be drawn that Hims & Hers will make additional updates with respect to those forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260602648634/en/

Contacts:

Press Contact
Susan Cadrecha
press@forhims.com

Source: Hims & Hers